ADDENDUM: Section E9 of the American College of Medical Genetics Technical Standards and Guidelines: Fluorescence in situ hybridization.

Autor: Mascarello JT; Genzyme Genetics, Santa Fe, NM, USA., Hirsch B; University of Minnesota Medical School, Minneapolis, MN, USA., Kearney HM; Fullerton Genetics Center, Asheville, NC, USA., Ketterling RP; Mayo Clinic College of Medicine, Rochester, MN, USA., Olson SB; Oregon Health and Science University, Portland, OR, USA., Quigley DI; Kaiser Permanente, NW, Portland, OR, USA., Rao KW; University of North Carolina, Chapel Hill, NC, USA., Tepperberg JH; Laboratory Corp America, Research Triangle Park, NC, USA., Tsuchiya KD; Seattle Children's Hospital and University of Washington Medical Center, Seattle, WA, USA., Wiktor AE; Mayo Clinic College of Medicine, Rochester, MN, USA.

Publikováno v: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2019 Oct; Vol. 21 (10), pp. 2405.

Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials.

Autor: Strickland SA; Vanderbilt-Ingram Cancer Center, Nashville, TN, United States. Electronic address: stephen.strickland@vanderbilt.edu., Sun Z; Frontier Science and Technology Research Foundation and Harvard School of Public Health, Boston, MA, United States., Ketterling RP; Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN, United States., Cherry AM; Stanford University School of Medicine, Stanford, CA, United States., Cripe LD; Indiana University Cancer Center, Indianapolis, IN, United States., Dewald G; Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN, United States., Fernandez HF; Moffitt Cancer Center and Research Institute, Tampa, FL, United States., Hicks GA; Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN, United States., Higgins RR; Cytogenetics Laboratory, Allina Health-Abbott Northwestern Hospital, Minneapolis, MN, United States., Lazarus HM; University Hospitals Cleveland Medical Center, Cleveland, OH, United States., Litzow MR; Division of Hematology, Mayo Clinic, Rochester, MN, United States., Luger SM; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, United States., Paietta EM; Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States., Rowe JM; Shaare Zedek Medical Center, Jerusalem, Israel., Vance GH; Indiana University School of Medicine, Indianapolis, IN, United States., Wiernik P; Cancer Research Foundation of New York, United States., Wiktor AE; Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN, United States., Zhang Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, United States., Tallman MS; Leukemia Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, United States.

Publikováno v: Leukemia research [Leuk Res] 2017 Aug; Vol. 59, pp. 55-64. Date of Electronic Publication: 2017 May 12.

Change in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory Using US Food and Drug Administration Criteria and American Society of Clinical Oncology and College of American Pathologists Guidelines.

Autor: Shah MV; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Wiktor AE; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Meyer RG; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Tenner KS; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Ballman KV; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Green SJ; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Sukov WR; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Ketterling RP; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Perez EA; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL., Jenkins RB; Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2016 Oct 10; Vol. 34 (29), pp. 3502-3510.

Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization:  Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes.

Autor: He R; From the Divisions of Hematopathology he.rong@mayo.edu., Wiktor AE; Laboratory Genetics., Durnick DK; From the Divisions of Hematopathology., Kurtin PJ; From the Divisions of Hematopathology., Van Dyke DL; Laboratory Genetics., Tefferi A; Hematology, Mayo Clinic College of Medicine, Rochester, MN., Patnaik MS; Hematology, Mayo Clinic College of Medicine, Rochester, MN., Ketterling RP; From the Divisions of Hematopathology Laboratory Genetics., Hanson CA; From the Divisions of Hematopathology Laboratory Genetics.

Publikováno v: American journal of clinical pathology [Am J Clin Pathol] 2016 Jul; Vol. 146 (1), pp. 86-94. Date of Electronic Publication: 2016 Jun 27.

Conventional karyotyping and fluorescence in situ hybridization: an effective utilization strategy in diagnostic adult acute myeloid leukemia.

Autor: He R; From the Divisions of Hematopathology and He.Rong@mayo.edu., Wiktor AE; Laboratory Genetics, Department of Laboratory Medicine and Pathology, and., Hanson CA; From the Divisions of Hematopathology and., Ketterling RP; Laboratory Genetics, Department of Laboratory Medicine and Pathology, and., Kurtin PJ; From the Divisions of Hematopathology and., Van Dyke DL; Laboratory Genetics, Department of Laboratory Medicine and Pathology, and., Litzow MR; Division of Hematology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN., Howard MT, Reichard KK; From the Divisions of Hematopathology and.

Publikováno v: American journal of clinical pathology [Am J Clin Pathol] 2015 Jun; Vol. 143 (6), pp. 873-8.